Cytek Biosciences, Inc. · NASDAQ:CTKB
The Vanguard Group reported a 7.51% stake in Cytek Biosciences, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 30, 2025
The Vanguard Group reported a 7.51% stake in Cytek Biosciences, Inc., 9,622,008 shares, as a passive investor on Mar 31, 2025. Filed Apr 30, 2025 (Schedule 13G/A).
- Stake
- 7.51%
- Shares
- 9,622,008
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 7.51% | 9,622,008 |
Source
Related
- Cytek Biosciences, Inc.
- The Vanguard Group
- Cytek Biosciences, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · The Vanguard Group · Jul 29, 2025
- Form 4 · Jiang Wenbin · Aug 20, 2026
- Form 4 · McCombe William D. · Aug 20, 2026
- Form 4 · Muir Glenn P · Aug 20, 2026
- Form 4 · Holder Michael · Aug 20, 2026
- Form 4 · Chin Richard · Aug 20, 2026